Internal Medicine, Endocrinology, Diabetes, & Metabolism · Houston, TX
NPI
1629229554
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
354 services
Medicare patients, 2024
212
Average age 71
Drug cost, 2024
$1.9M
310 prescriptions
Company payments, 2025
$140
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramona Dadu was code 99215 (office e&m - established), 104 times for 49 patients. In total Ramona Dadu billed 354 services in 15 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 104 | 49 | $109.68 | $11K |
| 99214 Office E&M - Established | Facility | 95 | 78 | $70.44 | $6,692 |
| 99232 Hospital E&M - Subsequent | Facility | 18 | 12 | $62.86 | $1,131 |
| 99214 Office E&M - Established | Office | 18 | 18 | $97.38 | $1,753 |
| 99222 Hospital E&M - Initial | Facility | 18 | 18 | $104.55 | $1,882 |
| 99221 Hospital E&M - Initial | Facility | 16 | 16 | $66.64 | $1,066 |
| 99205 Office E&M - New | Facility | 16 | 16 | $144.83 | $2,317 |
| 99204 Office E&M - New | Facility | 14 | 14 | $91.34 | $1,279 |
By year: 2022 $37K for 433 services; 2023 $31K for 369 services; 2024 $32K for 354 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramona Dadu prescribed most often to Medicare patients was Mekinist (Trametinib Dimethyl Sulfoxide), with 56 prescriptions and refills. In total Ramona Dadu wrote 310 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mekinist Trametinib Dimethyl Sulfoxide | 56 | 60 | Under 11 | $758K |
| Tafinlar Dabrafenib Mesylate | 54 | 56 | Under 11 | $645K |
| Levothyroxine Sodium Generic | 52 | 120 | 29 | $451 |
| Synthroid Levothyroxine Sodium | 25 | 43 | 11 | $2,081 |
| Everolimus Generic | 14 | 14 | Under 11 | $61K |
| Prochlorperazine Maleate Generic | 14 | 14 | 11 | $158 |
Brand drugs: 175 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramona Dadu $140 ($140 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $140.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $140 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.